Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-07

Clinical Trial Update: Collection of Liquid Biopsy Samples of Neuroendocrine Neoplasms (NEN) Patients - Collection of NET (CollectNET) 2.0, a Study by the BE-FORCE Consortium

View source ↗

Summary

CollectNET 2.0 is a BE-FORCE consortium study recruiting neuroendocrine neoplasm patients to collect liquid biopsy samples. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Antwerp | Conditions: Neuroendocrine Neoplasms | Status: RECRUITING